Effectiveness of Long-Term Opioid Therapy for Chronic Low Back Pain

References

1. 1.↵
   1. Vos T,
   2. Flaxman AD,
   3. Naghavi M,
   4. et al

   . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163–96.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Wu A,
   2. March L,
   3. Zheng X,
   4. et al

   . Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017. Ann Transl Med 2020;8:299.

   OpenUrl
3. 3.↵
   1. Dowell D,
   2. Haegerich TM,
   3. Chou R

   . CDC Guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Rep 2016;65:1–49.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Dowell D,
   2. Ragan KR,
   3. Jones CM,
   4. Baldwin GT,
   5. Chou R

   . CDC Clinical practice guideline for prescribing opioids for pain — United States, 2022. MMWR Recomm Rep 2022;71:1–95.

   OpenUrl
5. 5.↵
   1. Qaseem A,
   2. Wilt TJ,
   3. McLean RM

   , Clinical Guidelines Committee of the American College of Physicianset al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017;166:514–30.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Chou R,
   2. Turner JA,
   3. Devine EB,
   4. et al

   . The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med 2015;162:276–86.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Foster NE,
   2. Anema JR,
   3. Cherkin D

   , Lancet Low Back Pain Series Working Groupet al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet 2018;391:2368–83.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Chiarotto A,
   2. Koes BW

   . Nonspecific low back pain. N Engl J Med 2022;386:1732–40.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Busse JW,
   2. Bartlett SJ,
   3. Dougados M,
   4. et al

   . Optimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 Workshop. J Rheumatol 2015;42:1962–70.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Busse JW,
    2. Wang L,
    3. Kamaleldin M,
    4. et al

    . Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA 2018;320:2448–60.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Krebs EE,
    2. Gravely A,
    3. Nugent S,
    4. et al

    . Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA 2018;319:872–82.

    OpenUrlCrossRefPubMed
12. 12.↵
    ClinicalTrials.gov. PRECISION Pain Research Registry (PRECISION). Available at: https://clinicaltrials.gov/ct2/show/NCT04853732. Accessed July 24, 2023.
13. 13.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M

    , STROBE Initiativeet al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573–7.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Deyo RA,
    2. Dworkin SF,
    3. Amtmann D,
    4. et al

    . Report of the NIH Task Force on research standards for chronic low back pain. J Pain 2014;15:569–85.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Sullivan MJ

    . The Pain Catastrophizing Scale: User Manual. Montreal, QC: McGill University; 2009.
16. 16.↵
    1. Nicholas MK

    . The pain self-efficacy questionnaire: taking pain into account. Eur J Pain 2007;11:153–63.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    PROMIS. Adult Profile Instruments. Evanston, IL: Northwestern University; 2015.
18. 18.↵
    1. Austin PC

    . Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J 2009;51:171–84.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Roland M,
    2. Morris R

    . A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976) 1983;8:141–4.

    OpenUrl
20. 20.↵
    1. Dutmer AL,
    2. Reneman MF,
    3. Schiphorst Preuper HR,
    4. Wolff AP,
    5. Speijer BL,
    6. Soer R

    . The NIH minimal dataset for chronic low back pain: responsiveness and minimal clinically important change. Spine (Phila Pa 1976) 2019;44:E1211–E1218.

    OpenUrl
21. 21.↵
    1. Assendelft WJ,
    2. Morton SC,
    3. Yu EI,
    4. Suttorp MJ,
    5. Shekelle PG

    . Spinal manipulative therapy for low back pain. A meta-analysis of effectiveness relative to other therapies. Ann Intern Med 2003;138:871–81.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Von Korff M,
    2. Merrill JO,
    3. Rutter CM,
    4. Sullivan M,
    5. Campbell CI,
    6. Weisner C

    . Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain 2011;152:1256–62.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    National Library of Medicine. RxNorm Overview. Available at: https://www.nlm.nih.gov/research/umls/rxnorm/overview.html. Accessed July 24, 2023.
24. 24.↵
    1. Muller L,
    2. Gangadharaiah R,
    3. Klein SC,
    4. et al

    . An open access medical knowledge base for community driven diagnostic decision support system development. BMC Med Inform Decis Mak 2019;19:93.

    OpenUrl
25. 25.↵
    1. Campbell G,
    2. Noghrehchi F,
    3. Nielsen S,
    4. et al

    . Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: findings from a 5-year prospective cohort study. EClinicalMedicine 2020;28:100592.

    OpenUrl
26. 26.↵
    1. Degenhardt L,
    2. Hungerford P,
    3. Nielsen S,
    4. et al

    . Pharmaceutical opioid use patterns and indicators of extramedical use and harm in adults with chronic noncancer pain, 2012-2018. JAMA Netw Open 2021;4:e213059.

    OpenUrl
27. 27.↵
    1. Graham JW,
    2. Olchowski AE,
    3. Gilreath TD

    . How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci 2007;8:206–13.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Ballinger GA

    . Using generalized estimating equations for longitudinal data analysis. Organ Res Methods 2004;7:127–50.

    OpenUrlCrossRefWeb of Science
29. 29.↵
    1. Hubbard AE,
    2. Ahern J,
    3. Fleischer NL,
    4. et al

    . To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology 2010;21:467–74.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Kreidler SM,
    2. Muller KE,
    3. Grunwald GK,
    4. et al

    . GLIMMPSE: Online power computation for linear models with and without a baseline covariate. J Stat Softw 2013;54:
31. 31.↵
    1. Chou R,
    2. Deyo R,
    3. Friedly J,
    4. et al

    . Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians clinical practice guideline. Ann Intern Med 2017;166:480–92.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Cohen KR

    . Management of chronic low back pain. JAMA Intern Med 2022;182:222–3.

    OpenUrl
33. 33.↵
    1. Dowell D,
    2. Ragan KR,
    3. Jones CM,
    4. Baldwin GT,
    5. Chou R

    . Prescribing opioids for pain - the new CDC clinical practice guideline. N Engl J Med 2022;387:2011–3.

    OpenUrlCrossRef
34. 34.↵
    1. DiPrete BL,
    2. Ranapurwala SI,
    3. Maierhofer CN,
    4. et al

    . Association of opioid dose reduction with opioid overdose and opioid use disorder among patients receiving high-dose, long-term opioid therapy in North Carolina. JAMA Netw Open 2022;5:e229191.

    OpenUrl
35. 35.↵
    1. Lauer MS,
    2. D'Agostino RB Sr.

    . The randomized registry trial–the next disruptive technology in clinical research? N Engl J Med 2013;369:1579–81.

    OpenUrlCrossRefPubMedWeb of Science
36. 36.↵
    1. Hulley SB,
    2. Cummings SR,
    3. Browner WS,
    4. Grady DG,
    5. Newman TB

    . Designing Clinical Research. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.